Was great, now average - Associate Director bei MSD: Mitarbeiterbewertung

4.0
24. Apr. 2025
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Decent pay, good team, nice offices

Kontras

As key drug Keytruda approaches end of patent, company is in flux. Cost cutting and pressure increase.

Mehr Bewertungen zu MSD entdecken

5.0
4. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great team to work and grow with, also good learning enviroment

Kontras

My entry time was not the best timing, during the middle of the war wirh Iran, so work was slow and over 200 people from that site were let go, including myself

3.0
4. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great place to for early career as many opportunities to learn

Kontras

Very slow growth and limited opportunities for career advancement

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle